生物医药行业高价值专利数据

生物医药行业高价值专利数据库中主要包括了全球专利数据库中有生物医药行业制造的发明专利和实用新型专利数据，并根据自有算法对专利数据进行了检索、评价打分，有助于了解生物医药行业知识产权申请情况及地域布局；通过对各企业生物医药行业专利数据的对比，可了解各企业的技术创新能力；了解生物医药行业技术发展趋势及核心技术，有助于企业避免重复研发及侵犯他人的知识产权。数据基于AHP层次法，采用定量与定性相结合，从专利价值度法出发，指标层将专利价值指标体系分为技术、法律、经济3项一级指标，一级指标层向下为二级指标，包括技术价值指标：独立权利要求数量、主权项字数、剩余有效期(年)、同族专利数、引证其它专利数、被其他专利引证数、发明人投入人数、涉及领域数；法律价值指标：专利类型、文献页数、被无效请求次数；经济价值指标：转让次数、许可次数、质押融资次数、专利奖得分、海关备案得分；根据一级、二级指标建立3个维度的矩阵，通过专利接口数据获取专利评价对应的数据指标，采用1-9分标度法（最低为1分，最高为9分），求得相应的指标权重，用权重技术各个指标的分值，所有指标分值的和即为专利得分，根据分值的区间段对专利进行划分，80-100为高价值专利、60-80位重要专利、60分以下为一般专利，为生物医药行业企业研发人员提供技术参考及指引，为公司提供研发决策指导。

This high-value patent database for the biopharmaceutical industry mainly includes invention patents and utility model patents related to biopharmaceutical manufacturing from the global patent database. It has conducted retrieval and evaluation scoring on the patent data using proprietary algorithms, which helps to understand the intellectual property (IP) filing status and geographic layout of the biopharmaceutical industry. By comparing the patent data of enterprises in the biopharmaceutical industry, users can grasp the technological innovation capabilities of each enterprise; understanding the technological development trends and core technologies of the industry also helps enterprises avoid redundant R&D and intellectual property infringement.

The data is based on the Analytic Hierarchy Process (AHP), combining quantitative and qualitative methods starting from the patent valuation methodology. The index system divides patent value metrics into three first-level indicators: technical, legal, and economic value, with corresponding second-level indicators under each category. The technical value indicators include: number of independent claims, word count of the independent claim, remaining validity period (years), number of patent families, number of cited external patents, number of times cited by other patents, number of inventor contributors, and number of involved technical fields. The legal value indicators include: patent type, number of document pages, and number of received invalidation requests. The economic value indicators include: number of transfers, number of licensing activities, number of pledge financing cases, patent award score, and customs recordation score.

A three-dimensional matrix is established based on the first-level and second-level indicators. The required data indicators for patent evaluation are obtained through patent interface data. The 1-9 scaling method (with 1 being the lowest score and 9 being the highest) is adopted to calculate the weight of each indicator, and the scores of individual indicators are weighted using these weights. The sum of all weighted indicator scores constitutes the total patent score. Patents are classified into three categories based on their total scores: high-value patents (80-100), important patents (60-80), and general patents (below 60). This database provides technical references and guidance for R&D personnel of biopharmaceutical enterprises, and supports R&D decision-making for companies.

搜集汇总

数据集介绍

特点

该数据集包含1636条生物医药行业的高价值专利数据，每年更新一次，用于分析行业知识产权情况和企业技术创新能力。数据通过AHP层次法从技术、法律、经济三个维度评分，划分专利价值等级。